Codon 12 ras mutations in patients with myelodysplastic syndrome: Incidence and prognostic value

Annals of Hematology

Volumn 74, Issue 1, 1997, Pages 11-14

  Constantinidou, M ^a   Chalevelakis, G ^a   Economopoulos, T ^a   Koffa, M ^b   Liloglou, T ^b   Anastassiou, C ^a   Yalouris, A ^a   Spandidos, D A ^b   Raptis, S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Myelodysplastic syndrome; Polymerase chain reaction; ras point mutation

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CHRONIC MYELOMONOCYTIC LEUKEMIA; CODON; FEMALE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CODON; FEMALE; GENES, RAS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POINT MUTATION; PROGNOSIS;

EID: 0031036777     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050248     Document Type: Article

References (21)

1. Bar-Eli M, Ahuja H, Gonzales-Cadavid N, Foti A, Cline MJ (1989) Analysis of N-ras exon I mutations in myelodysplasia detected by amplification, oligonucleotide hybridization and transformation. Blood 73:281-283
2. Barbacid M (1987) Ras gene. Ann Rev Biochem 56:779-827
3. Bennett JM, Catovsky D, Daniel MT, Daniel MT, Flandrin G, Gallon D, Granlick HR, Sultan C (1982) Proposals of the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199
4. Browett PJ, Norton JD (1989) Analysis of ras gene mutations and methylation state in human leukemias. Oncogene 4:1029-1036
5. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Sottoft S (1991) Oncogenes and signal transduction. Cell 64:281-302
6. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA (1990) Stimulation of p21ras upon T-cell activation. Nature 346:719-723
7. Economopoulos T, Stathakis N, Foudoulakis A, Papadoulis N, Dervenoulas J, Papageorgiou E, Anastassiou C, Hadjioannou J, Raptis S (1987) Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. Eur J Haematol 38:338-344
8. Janssen JWG, Steenvoorden ACM, Lyons J, Anger B, Bohlke JU, Bos JL, Seliger H, Bartman CR (1987) Ras gene mutation in acute and chronic myelocytic leukemia, chronic myeloproliferative disorders and myelodysplastic syndromes. Proc Natl Acad Sci USA 84:9228-9232
9. Liu E, Hjelie B, Morgan R, Hecht F, Bishop JM (1987) Mutation of the Kirsten-ras proto-oncogene in human preleukemia. Nature 300:186-188
10. Lyons J, Jansen JWG, Bartam C, Layton M, Multi GJ (1988) Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 71:1707-1712
11. Mano H, Ishikawa F, Hirai H, Takaku F (1989) Mutations of N-ras oncogenes in myelodysplastic syndromes and leukemias detected by polymerase chain reaction. Jpn J Cancer Res 80:102-106
12. Mufti GJ, Galton DAG (1986) Myelodysplastic syndrome: natural history and features of prognostic importance. Clin Haematol 15:953-971
13. Nakayawa T, Saitoh S, Imato S, Hoh M, Tsutsumi M, Hikiji K, Nakamura H, Matoraal S, Ogawa R, Nakao Y, Fujita T (1992) Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia. Oncology 49:114-122
14. Neubauer A, Greenberg P, Nergin R, Ginzten N, Lie E (1994) Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. Leukemia 4:638-641
15. Padua RA, Carter G, Hughes D, Gow J, Farr C, Oscier D, McCormick F, Jacobs A (1988) Ras mutations in myelodysplasia detected by amplification oligonucleotide hybridization and transformation. Leukemia 2:503-510
16. Paquette RL, Landaw EA, Pierre RV, Kahan J, Lublert M, Lazcano O, Isaac G, McCormick E, Koeffler P (1993) N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood 82:590-599
17. Spandidos DA, Liloglou T, Arvanitis D, Gourtsoyiannis NC (1993) Ras gene activation in human small intestinal tumors. Int J Oncol 2:513-518
18. Taparowsky E, Shimizu GM, Wigler M (1983) Structure and activation of the human N-ras gene. Cell 34:581-586
19. Van Kamp H, de Pijoper C, Varlaan-de Vries M, Bos JL, Lickama CHW, Kerkfos H, Willemze R, Fibbe WE, Landegent JE (1992) Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears. Blood 79:1266-1270
20. Yiagnisis M, Spandidos DA (1987) Interleukin 3-like activity secreted from human RAS of MYC transfected rodent cells. Anticancer Res 7:1293-1297
21. Yunis JJ, Boot AJM, Mayer MG, Bos JL (1989) Mechanism of RAS mutation in myelodysplastic syndrome. Oncogene 4:609-614